Follow
Jason L. Schwartz
Jason L. Schwartz
Associate Professor of Health Policy and the History of Medicine, Yale University
Verified email at yale.edu - Homepage
Title
Cited by
Cited by
Year
Clinical Outcomes Of A COVID-19 Vaccine: Implementation Over Efficacy
AD Paltiel, JL Schwartz, A Zheng, RP Walensky
Health Affairs 40 (1), 42-52, 2021
1972021
Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA
SB Omer, RM Benjamin, NT Brewer, AM Buttenheim, T Callaghan, ...
The Lancet 398 (10317), 2186-2192, 2021
1142021
New directions: The ethics of synthetic biology and emerging technologies
Presidential Commission for the Study of Bioethical Issues
DC: Presidential Commission for the Study of Bioethical Issues, 2010
105*2010
Evaluating and deploying COVID-19 vaccines—The importance of transparency, scientific integrity, and public trust
JL Schwartz
New England Journal of Medicine 383 (18), 1703-1705, 2020
892020
New media, old messages: themes in the history of vaccine hesitancy and refusal
JL Schwartz
AMA Journal of Ethics 14 (1), 50-55, 2012
742012
Lessons from the failure of human papillomavirus vaccine state requirements
JL Schwartz, AL Caplan, RR Faden, J Sugarman
Clinical Pharmacology & Therapeutics 82 (6), 760-763, 2007
722007
Speed versus efficacy: quantifying potential tradeoffs in COVID-19 vaccine deployment
AD Paltiel, A Zheng, JL Schwartz
Annals of internal medicine 174 (4), 568-570, 2021
622021
Vaccination refusal: ethics, individual rights, and the common good
JL Schwartz, AL Caplan
Primary Care: Clinics in Office Practice 38 (4), 717-728, 2011
582011
COVID-19 vaccination of minors without parental consent: respecting emerging autonomy and advancing public health
L Morgan, JL Schwartz, DA Sisti
JAMA pediatrics 175 (10), 995-996, 2021
462021
The first rotavirus vaccine and the politics of acceptable risk
JL Schwartz
The Milbank Quarterly 90 (2), 278-310, 2012
432012
The Spanish flu, epidemics, and the turn to biomedical responses
JL Schwartz
American journal of public health 108 (11), 1455-1458, 2018
402018
HPV vaccination's second act: promotion, competition, and compulsion
JL Schwartz
American Journal of Public Health 100 (10), 1841-1844, 2010
382010
State-level voting patterns and adolescent vaccination coverage in the United States, 2014
S Bernstein, A North, J Schwartz, LM Niccolai
American journal of public health 106 (10), 1879-1881, 2016
352016
Ethics of vaccination programs
JL Schwartz, AL Caplan
Current opinion in virology 1 (4), 263-267, 2011
322011
Speed, evidence, and safety characteristics of vaccine approvals by the US Food and Drug Administration
J Puthumana, AC Egilman, AD Zhang, JL Schwartz, JS Ross
JAMA Internal Medicine 181 (4), 559-560, 2021
292021
Achieving an optimal childhood vaccine policy
DJ Opel, JL Schwartz, SB Omer, R Silverman, J Duchin, E Kodish, ...
JAMA pediatrics 171 (9), 893-896, 2017
292017
Excess Death Rates for Republican and Democratic Registered Voters in Florida and Ohio During the COVID-19 Pandemic
J Wallace, P Goldsmith-Pinkham, JL Schwartz
JAMA Internal Medicine 183 (9), 916-923, 2023
28*2023
Real‐world evidence, public participation, and the FDA
JL Schwartz
Hastings Center Report 47 (6), 7-8, 2017
272017
State vaccination requirements for HPV and other vaccines for adolescents, 1990-2015
JL Schwartz, LA Easterling
Jama 314 (2), 185-186, 2015
272015
Unintended consequences: the primacy of public trust in vaccination
JL Schwartz
Mich. L. Rev. First Impressions 107, 100, 2008
272008
The system can't perform the operation now. Try again later.
Articles 1–20